Associated Papers
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors.
Pecci F et al.
Cancer Discovery, 2024
38564707 (PubMed )
Supplement: cd-23-1217_supplementary_table_4_suppst4.xlsx › Sheet2
MET is a new confirmed gene responsible for familial distal arthrogryposis.
Maffeo D et al.
Embo Molecular Medicine, 2024
Identifying Actionable Variants Using Capture-Based Targeted Sequencing in 563 Patients With Non-Small Cell Lung Carcinoma.
Jiang H et al.
Frontiers in Oncology, 2021
35186718 (PubMed )
Supplement: Table_1.xlsx › Supplementary_Table_2
MET mutation causes muscular dysplasia and arthrogryposis.
Zhou H et al.
Embo Molecular Medicine, 2019
Select a paper to view details